Investigates the key genomic change in cancers and reproduce and demonstrate the effect in vitro/vivo
My research interest is focused on investigating key regulatory genes/elements and pathways involved in cancer development from the perspective of genetic alterations. In particular, I am interested in identification of characteristic genetic change which explains phenotype or sensitivity to drugs in a subset of tumors. Moreover, by the integration of next-generation sequencing data with the use of in vivo/vitro patient-derived xenografts and cancer cells, I aim to reproduce and demonstrate their involvement in cancer development. These developed models not only help the better understanding of the mechanism underlie a subset of tumors but also helps the development of novel approaches toward the personalized treatment for patients.
The Jackson Laboratory
Postdoctoral Associate
Adv: Edison Liu
2017-2019
RIKEN (Japan)
Research Fellow
Adv: Hidewaki Nakagawa
2012-2017
Tokyo Medical and Dental University (Japan)
Ph.D., Molecular Biology
Adv: Johji Inazawa
2009-2012
Tokyo Medical and Dental University (Japan)
MSc., Molecular Biology
2007-2009
Tokyo University of Science (Japan)
B.S., Biology
2007
The Jackson Laboratory
Associate Research ScientistAdv: Edison Liu
2019-present
Tokyo Medical and Dental University (Japan)
Research Assistant
2008-2009, 2011-2012
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.